Clinical trial
Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms
NCT00468936 · McGill University Health Centre/Research Institute of the McGill University Health Centre, Other · Unknown status
Key facts
| NCT number | NCT00468936 |
|---|---|
| Title | Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms |
| Official title | Open-Label, Randomized Study Comparing the Patient Reported Severity of GI Side Effects of MMF Versus EC-MPS in Maintenance Heart Transplant Patients. |
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre, Other |
| Collaborators | Novartis Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Transplant Patients |
| Intervention type | Drug |
| Interventions | Myfortic |
| Enrollment | 100 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | May 3, 2007 |
| Last update posted | Oct 17, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: